Original Articles

Evaluation of urinary tract infection agents in intensive care unit patients and monitoring of antimicrobial profile in Gram-negative bacteria

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 21 November 2024
Accepted: 2 January 2025
Published: 7 July 2025
309
Views
194
Downloads
6
HTML

Authors

Background: urinary tract infection is one of the most common complications in intensive care patients. This study aimed to determine the microorganisms grown in the urine cultures of patients treated in the intensive care units of our hospital and to evaluate the resistance status of the isolated Gram-negative bacteria to antibiotics.

Materials and Methods: the distribution of microorganisms isolated from urine cultures of intensive care patients in our hospital's microbiology laboratory between January 2018 and December 2022 and the resistance patterns of Gram-negative bacteria to antibiotics were evaluated retrospectively.

Results: there was significant growth in 391 (21%) of 1855 urine cultures. 84.6% (n=331) of the samples belonged to patients treated in the general intensive care unit. Gram-positive bacteria were found in 9.4% (n=37), Candida species in 28.9% (n=113), and Gram-negative bacteria in 61.6% (n=241) of the cultures. The most frequently isolated Gram-positive microorganism was Enterococcus spp., while the Gram-negative pathogen was E. coli. Ciprofloxacin resistance was 48.3% in E. coli and 65% in K. pneumoniae, and amoxicillin-clavonic acid resistance was 42.6% in E. coli and 80% in K. pneumoniae. Ciprofloxacin resistance in Proteus and Pseudomonas strains was 53.3% and 52.9%, respectively. All A. baumannii strains were resistant to carbapenem and ciprofloxacin.

Conclusions: considering the resistance rates obtained in the study, amikacin is considered an appropriate treatment option for patients in our hospital. Due to high resistance rates, the use of carbapenems and quinolones should be avoided in the treatment of A. baumannii. Carbapenem and amikacin are considered suitable treatment options for the treatment of E. coli and K. pneumoniae strains, and Trimethoprim/Sulfamethoxazole (TMP-SMX) for the treatment of A. baumannii strains.

Downloads

Download data is not yet available.
Ahmadi M, Ranjbar R, Behzadi P, Mohammadian T. Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella pneumoniae. Expert Review of Anti-Infective Therapy 2022;20:463-72. DOI: https://doi.org/10.1080/14787210.2022.1990040
Alfouzan WA, Dhar R. Candiduria: evidence-based approach to management, are we there yet? Journal de Mycologie Medicale 2017;27:293-302. DOI: https://doi.org/10.1016/j.mycmed.2017.04.005
Alos JI. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enfermedades Infecciosas y Microbiologia Clinica 2005;23:3-8.
Avcıoğlu F, Behçet M. Evaluation of resistance rates of Escherichia coli isolates of urinary tract infection to various antibiotics. Turk Mikrobiyol Cemiyeti Dergisi 2020;50:172-7. DOI: https://doi.org/10.5222/TMCD.2020.172
Baran C, Küçükcan A. Antimicrobial susceptibility of bacteria isolated from urine cultures in Southern Turkey. Current Urology 2022;16:180-4. DOI: https://doi.org/10.1097/CU9.0000000000000144
Farrell D, Morrissey I, De Rubeis D, et al. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. Journal of Infection 2003;46:94-100. DOI: https://doi.org/10.1053/jinf.2002.1091
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology 2015;13:269-84. DOI: https://doi.org/10.1038/nrmicro3432
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-Month 2003;49:53-70. DOI: https://doi.org/10.1067/mda.2003.7
Gajdács M, Urbán E. Comparative epidemiology and resistance trends of proteae in urinary tract infections of inpatients and outpatients: a 10-year retrospective study. Antibiotics (Basel) 2019;8:91. DOI: https://doi.org/10.3390/antibiotics8030091
Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases 2011;52:e103-20. DOI: https://doi.org/10.1093/cid/ciq257
Hozzari A, Behzadi P, Kerishchi Khiabani P, et al. Clinical cases, drug resistance, and virulence genes profiling in uropathogenic Escherichia coli. Journal of Applied Genetics 2020;61:265-73. DOI: https://doi.org/10.1007/s13353-020-00542-y
İgan H, Hancı H. Distribution of microorganisms and antibiotic resistance of Gram-negative bacteria isolated from urine cultures of intensive care unit patients during the last four years. Turk Yogun Bakim Dergisi 2022;20. DOI: https://doi.org/10.4274/tybd.galenos.2020.33154
Jiménez-Guerra G, Heras-Cañas V, Gutiérrez-Soto M, et al. Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives. Journal of Medical Microbiology 2018;67:790-7. DOI: https://doi.org/10.1099/jmm.0.000742
Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS project. Journal of Antimicrobial Chemotherapy 2003;51:69-76. DOI: https://doi.org/10.1093/jac/dkg028
Khodabandeh M, Mohammadi M, Abdolsalehi MR, et al. High-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus faecium; as a serious threat in hospitals. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders) 2020;20:223-8. DOI: https://doi.org/10.2174/22123989OTQ5pMTgbTcVY
MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. Journal of Intensive Care Medicine 2017;32:25-37. DOI: https://doi.org/10.1177/0885066615619895
Majumder M, Ahmed T, Hossain D, Begum S. Bacteriology and antibiotic sensitivity patterns of urinary tract infections in a tertiary hospital in Bangladesh. Mymensingh Medical Journal 2014;23:99-104.
Odabasi Z, Mert A. Candida urinary tract infections in adults. World Journal of Urology 2020;38:2699-707. DOI: https://doi.org/10.1007/s00345-019-02991-5
Orucu M, Geyik MF. The frequent nosocomial infections in intensive care units. Duzce Medical Journal 2008;10:40-3.
Ozturk R, Murt A. Epidemiology of urological infections: a global burden. World Journal of Urology 2020;38:2669-79. DOI: https://doi.org/10.1007/s00345-019-03071-4
Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clinical Microbiology and Infection 2019;25:951-7. DOI: https://doi.org/10.1016/j.cmi.2019.03.014
Sarshar M, Behzadi P, Ambrosi C, et al. FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics 2020;9:397. DOI: https://doi.org/10.3390/antibiotics9070397
Tandogdu, Zafer, FME Wagenlehner. Global epidemiology of urinary tract infections. Current Opinion in Infectious Diseases 2016;29:73-9. DOI: https://doi.org/10.1097/QCO.0000000000000228
Taşbakan MI, Pullukçu H, Sipahi OR, et al. A pooled analysis of the resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a comparison of the periods 1997- 2001 and 2002-2007. Turkish Journal of Medical Sciences 2011;41:557-64. DOI: https://doi.org/10.3906/sag-1006-893
Türe Z, Ersoy S, Kalın G, Altun D, et al. The incidence of ıntensive care unit-acquired nosocomial urinary tract infections: microorganisms and susceptibilities in a university hospital. FLORA 2015;20:188-94
European Association of Urologists (EAU). Urological Infections. 2024. Available from: https://uroweb.org/guidelines/urological-infections
Ün S, Yılmaz Y, Yıldırım M, et al. Investigation of prevalence and risk factors for hospital-acquired urinary tract infections in patients with severe burn injury. Ulus Travma Acil Cerrahi Dergisi 2015;21:57-62. DOI: https://doi.org/10.5505/tjtes.2015.35920

How to Cite



Evaluation of urinary tract infection agents in intensive care unit patients and monitoring of antimicrobial profile in Gram-negative bacteria. (2025). Microbiologia Medica, 40(1). https://doi.org/10.4081/mm.2025.13410